Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:52 AM
Ignite Modification Date:
2025-12-24 @ 11:52 AM
NCT ID:
NCT02503761
Eligibility Criteria:
Inclusion Criteria:
* Neonates admitted to the neonatal care unit (NCU) who suffer from late onset sepsis (LOS) at admission or during their NICU stay and receive meropenem for at least four days
Exclusion Criteria:
* Acute or chronic renal failure
* Hypersensitivity or allergy to meropenem
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
3 Days
Maximum Age:
4 Weeks
Study:
NCT02503761
Study Brief:
Protocol Section:
NCT02503761